title: Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
authors.affiliation: Department of Pathology, Harvard Medical School, Boston, Massachusetts.
authors.forename: M J
authors.initials: MJ
authors.lastname: Karnovsky
authors.forename: T C
authors.initials: TC
authors.lastname: Wright
authors.forename: J J
authors.initials: JJ
authors.lastname: Castellot
authors.forename: J
authors.initials: J
authors.lastname: Choay
authors.forename: J C
authors.initials: JC
authors.lastname: Lormeau
authors.forename: M
authors.initials: M
authors.lastname: Petitou
mesh_terms: D000818:Animals; D000990:Antithrombin III / Q000378:metabolism; D001161:Arteriosclerosis / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D004730:Endothelium, Vascular / Q000473:pathology; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology*; D015394:Molecular Structure; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D013329:Structure-Activity Relationship; D013431:Sulfates / Q000378:metabolism
chemical_list: D000990:Antithrombin III; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; D013431:Sulfates